Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human mesangial cells and induce interleukin-6 and plasminogen activator inhibitor-1 secretion

Our findings suggest that a maternal autoantibody with the ability to activate AT1 receptors may account for the development of renal damage seen in preeclamptic patients.